跳至主要内容
临床试验/NCT05919654
NCT05919654进行中(未招募)不适用

Clinical Evaluation of MyoCare in Europe (CEME): Study Protocol for a Prospective, Multicenter, Randomized, Double-blinded, and Controlled Clinical Trial.

Universidad Complutense de Madrid2 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2022年9月15日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
300
试验地点
2
主要终点
Objective refraction

研究概览

简要总结

A 2-year prospective, multicenter, randomized controlled, and double-blind clinical trial is used to investigate the efficacy of a new design of ophthalmic lenses to slow the progression of myopia. 300 children aged from 6 to 13 years old will be recruited and randomly assigned to a study or control group. The study group will be composed of 150 children wearing MyoCare while the control group will be composed of 150 children wearing Clearview. The inclusion criteria will be myopia with a spherical equivalent between -0.75D and -5.00D, astigmatism < 1.50D, and anisometropia < 1.00D, as well as having a historical evolution of at least -0.50 The primary outcome is to compare the mean annual progression of the spherical equivalent between both groups. The secondary outcomes are axial length, choroidal thickness, phorias, and accommodative status of both groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
6 Years 至 13 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Age 6-13 years
  • Caucasian ethnicity
  • Monocular/binocular decimal visual acuity with correction ≥ 1.00
  • Spherical equivalent between -0.75D and -5.00D
  • Astigmatism < 1.50D
  • Anisometropia < 1.00D
  • Evolution of at least -0.50D in one year

排除标准

  • Presence of ocular pathology or a history of ocular and systemic abnormalities
  • Strabismus or binocular vision problems
  • History of eye surgery
  • Having previously used some method to control myopia.
  • Having contraindications for the application of drugs for cycloplegia/corneal anesthesia

结局指标

主要结局

Objective refraction

时间窗: 2 years

Objective refraction will be taken after cycloplegia as the mean of 3 measurements with the i.profiler (Carl Zeiss Meditec AG, Jena, Germany) autorefractometer. The mean annual progression of the objective refraction will be compared between myopic children treated with ZEISS MyoCare lenses and those who wear a conventional single-vision lens.

次要结局

  • Axial length(2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Clinical Evaluation of MyoCare in Europe (CEME) | 临床试验